Search
Monlunabant
go.drugbank.com/drugs/DB21537InvestigationalMonlunabant is a small molecule drug. The usage of the INN stem '-nabant' in the name indicates that Monlunabant is a cannabinoid receptor antagonist. … Monlunabant has a monoisotopic molecular weight of 590.11 Da.
Polvitolimod
go.drugbank.com/drugs/DB21548ExperimentalPolvitolimod is a small molecule drug. The usage of the INN stem '-tolimod' in the name indicates that Polvitolimod is a toll-like receptor (TLR) agonist. … Polvitolimod has a monoisotopic molecular weight of 323.1 Da.
Zevaquenabant
go.drugbank.com/drugs/DB21590ExperimentalZevaquenabant is a small molecule drug. The usage of the INN stem '-nabant' in the name indicates that Zevaquenabant is a cannabinoid receptor antagonist. … Zevaquenabant has a monoisotopic molecular weight of 547.11 Da.
Fulzerasib
go.drugbank.com/drugs/DB21609InvestigationalFulzerasib is a small molecule drug. The usage of the INN stem '-rasib' in the name indicates that Fulzerasib is a Ras protein inhibitor. … Fulzerasib has a monoisotopic molecular weight of 630.22 Da.
Upleganan
go.drugbank.com/drugs/DB21618InvestigationalUpleganan is a small molecule drug. Upleganan is under investigation in clinical trial NCT04865393 (Phase 1 Study of PK and Safety of SPR206 in Subjects With Various Degrees Of Renal Function). … Upleganan has a monoisotopic molecular weight of 1143.6 Da.
Bimatoprost grenod
go.drugbank.com/drugs/DB21634ExperimentalBimatoprost grenod is a small molecule drug. Bimatoprost grenod has a monoisotopic molecular weight of 574.33 Da.
Irucalantide
go.drugbank.com/drugs/DB21654ExperimentalIrucalantide is a small molecule drug. Irucalantide has a monoisotopic molecular weight of 1682.72 Da.
Setidegrasib
go.drugbank.com/drugs/DB21670InvestigationalSetidegrasib is a small molecule drug. The usage of the INN stem '-rasib' in the name indicates that Setidegrasib is a Ras protein inhibitor. … Setidegrasib has a monoisotopic molecular weight of 1116.48 Da.
Icotrokinra
go.drugbank.com/drugs/DB21724ApprovedInvestigationalIcotrokinra is a first-in-class, targeted oral peptide and interleukin-23 (IL-23) receptor antagonist. … [L56108,L56118] Icotrokinra was approved by the US FDA in March 2026 for the systemic treatment of moderate-to-severe plaque psoriasis.[L56108]
Vormatrigine
go.drugbank.com/drugs/DB21731InvestigationalVormatrigine is a small molecule drug. The usage of the INN stem '-trigine' in the name indicates that Vormatrigine is a sodium channel blocker, signal transduction modulator. … Vormatrigine has a monoisotopic molecular weight of 406.09 Da.